FDA Acknowledges Ligand Innovation Global’s Application for Emergency Use Authorization of LifeAir/VitaCaeli
March 03, 2022 09:00 ET
|
Forwardly, Inc.
Henderson, NV, March 03, 2022 (GLOBE NEWSWIRE) -- Forwardly, Inc. (OTCMKT: FORW) announced today that its partially owned subsidiary and partner, Ligand Innovation Global (“Ligand”), has received...